The Longevity Reporter: The Weekly Newsletter About Aging (subscribe to the newsletter)
View this email in your browser
4th March 2017
Connect With Us And Join The Discussion
This Week's Top Health And Longevity News 
Experimental Gene Therapy Making Strides Against Cancer: Over a third of patients receiving a new CAR-T cell therapy by Kite Pharma show no signs of cancer after 6 months. Source 
CRISPR Boosts Potency Of Immunotherapy Technique: CRISPR can enhance the effectiveness of chimeric antigen receptor (CAR) T cells, a revolutionary immunotherapy technique. Source 
Life Expectancy Will Continue To Increase: Using data from 35 industrialised countries, researchers have predicted that within these nations there is a 65% chance that lifespan will increase for women and an 85% chance for men. The biggest gains for life expectancy are likely to be found in South-Korea, Slovenia, and Portugal for women and in Hungary, South-Korea, and Slovenia for men. Source 
Gene Therapy Tackles Sickle Cell Disease: A 15 year old teenager with sickle cell disorder is living medicine free after a receiving a gene therapy treatment. Source 
A Simple Infographic On Telomeres And The Lifestyle Factors That Affect Them: While you can measure your chronological aging by-the-second by just looking at a clock, to see your biological age you must go down to deep within your cells, and take a peek at your chromosomes, specifically, the tips of your chromosomes called the telomeres. Here’s a simple visual explanation of telomeres and the lifestyle factors that affect them, from Arnas Butkus at One Goal Denver. Source 
Want More Longevity News -- Follow Us On Twitter, And Like Us On Facebook To Keep Updated On The Latest News About Longevity and Aging
Spread The Word About Longevity...Share This Newsletter
This newsletter was created and edited by Robert Powles and Avi Roy.

Copyright © 2017 The Longevity Reporter, All rights reserved.

subscribe to this list

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp